Promis Neurosciences Stock Fundamentals
| PMN Stock | USD 0.89 0.01 1.14% |
ProMIS Neurosciences fundamentals help investors to digest information that contributes to ProMIS Neurosciences' financial success or failures. It also enables traders to predict the movement of ProMIS Stock. The fundamental analysis module provides a way to measure ProMIS Neurosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProMIS Neurosciences stock.
ProMIS |
ProMIS Neurosciences Company Return On Equity Analysis
ProMIS Neurosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current ProMIS Neurosciences Return On Equity | -10.99 |
Most of ProMIS Neurosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProMIS Neurosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, ProMIS Neurosciences has a Return On Equity of -10.9851. This is 54.17% lower than that of the Biotechnology sector and 69.87% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
ProMIS Neurosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ProMIS Neurosciences's current stock value. Our valuation model uses many indicators to compare ProMIS Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ProMIS Neurosciences competition to find correlations between indicators driving ProMIS Neurosciences's intrinsic value. More Info.ProMIS Neurosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ProMIS Neurosciences' earnings, one of the primary drivers of an investment's value.ProMIS Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ProMIS Neurosciences' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ProMIS Neurosciences could also be used in its relative valuation, which is a method of valuing ProMIS Neurosciences by comparing valuation metrics of similar companies.ProMIS Neurosciences is currently under evaluation in return on equity category among its peers.
ProMIS Fundamentals
| Return On Equity | -10.99 | ||||
| Return On Asset | -4.81 | ||||
| Current Valuation | 7.52 M | ||||
| Shares Outstanding | 32.69 M | ||||
| Shares Owned By Insiders | 44.78 % | ||||
| Shares Owned By Institutions | 50.30 % | ||||
| Number Of Shares Shorted | 211.92 K | ||||
| Price To Book | 4.00 X | ||||
| Price To Sales | 5,168 X | ||||
| Gross Profit | (7.12 M) | ||||
| EBITDA | (17.81 M) | ||||
| Net Income | (17.51 M) | ||||
| Cash And Equivalents | 8.95 M | ||||
| Cash Per Share | 1.24 X | ||||
| Total Debt | 13.07 M | ||||
| Debt To Equity | 1.08 % | ||||
| Current Ratio | 5.42 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (14.37 M) | ||||
| Short Ratio | 2.64 X | ||||
| Earnings Per Share | 0.04 X | ||||
| Target Price | 7.67 | ||||
| Beta | 0.61 | ||||
| Market Capitalization | 29.09 M | ||||
| Total Asset | 18.04 M | ||||
| Retained Earnings | (123.84 M) | ||||
| Working Capital | 490.44 K | ||||
| Net Asset | 18.04 M |
About ProMIS Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProMIS Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProMIS Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProMIS Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Promis Neurosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Pair Trading with ProMIS Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with ProMIS Stock
Moving against ProMIS Stock
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ProMIS Neurosciences Piotroski F Score and ProMIS Neurosciences Altman Z Score analysis. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.